D2OC34 Stock Overview
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Doximity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$21.96 |
| 52 Week High | US$28.13 |
| 52 Week Low | US$16.50 |
| Beta | 1.17 |
| 1 Month Change | -4.94% |
| 3 Month Change | -10.48% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -48.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| D2OC34 | BR Healthcare Services | BR Market | |
|---|---|---|---|
| 7D | -1.2% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how D2OC34 performed against the BR Healthcare Services industry.
Return vs Market: Insufficient data to determine how D2OC34 performed against the BR Market.
Price Volatility
| D2OC34 volatility | |
|---|---|
| D2OC34 Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in BR Market | 0% |
| 10% least volatile stocks in BR Market | 0% |
Stable Share Price: D2OC34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine D2OC34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 900 | Jeff Tangney | www.doximity.com |
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems.
Doximity, Inc. Fundamentals Summary
| D2OC34 fundamental statistics | |
|---|---|
| Market cap | R$23.75b |
| Earnings (TTM) | R$711.53m |
| Revenue (TTM) | R$2.42b |
33.6x
P/E Ratio9.9x
P/S RatioIs D2OC34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| D2OC34 income statement (TTM) | |
|---|---|
| Revenue | US$468.33m |
| Cost of Revenue | US$51.78m |
| Gross Profit | US$416.55m |
| Other Expenses | US$278.92m |
| Earnings | US$137.63m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.74 |
| Gross Margin | 88.94% |
| Net Profit Margin | 29.39% |
| Debt/Equity Ratio | 0% |
How did D2OC34 perform over the long term?
See historical performance and comparison